Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06984718
What this trial is testing

A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC

Who this might be right for
HCCHepatocellular Carcinoma
Akeso 120
Testing effectiveness (Phase 2)UnknownNCT04961918
What this trial is testing

The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 36
Large-scale testing (Phase 3)Study completedNCT01164202
What this trial is testing

Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Federation Francophone de Cancerologie Digestive 78
Testing effectiveness (Phase 2)Study completedNCT02325739
What this trial is testing

FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression

Who this might be right for
Hepatocellular Carcinoma (HCC)Solid Malignancies
Novartis Pharmaceuticals 172
Testing effectiveness (Phase 2)Study completedNCT01375569
What this trial is testing

TRC105 for Liver Cancer That Has Not Responded to Sorafenib

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerCarcinoma, Hepatocellular
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Looking for participantsNCT07239245
What this trial is testing

Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

Who this might be right for
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Looking for participantsNCT06553885
What this trial is testing

Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC

Who this might be right for
Metastatic Colorectal CancerHepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 40
Testing effectiveness (Phase 2)Study completedNCT03463876
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib in Patients With Advanced HCC(RESCUE)

Who this might be right for
Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 190
Testing effectiveness (Phase 2)Study completedNCT00058487
What this trial is testing

Epirubicin and Thalidomide in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Dana-Farber Cancer Institute 12
Not applicableLooking for participantsNCT04933435
What this trial is testing

Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients

Who this might be right for
Liver Cancer
Duke University 78
Testing effectiveness (Phase 2)Study completedNCT03407495
What this trial is testing

The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular Carcinoma

Who this might be right for
Magnetic Resonance Imaging
MegaPro Biomedical Co. Ltd. 52
Testing effectiveness (Phase 2)UnknownNCT01259193
What this trial is testing

Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Fudan University 50
Testing effectiveness (Phase 2)WithdrawnNCT02997956
What this trial is testing

Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)

Who this might be right for
Hepatocellular Carcinoma
University of Michigan Rogel Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01642186
What this trial is testing

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

Who this might be right for
Fibrolamellar CarcinomaFibrolamellar Liver Cancer
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT00405873
What this trial is testing

Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003

Who this might be right for
Hepatocellular Carcinoma
Auron Healthcare GmbH 73
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Temporarily pausedNCT06405061
What this trial is testing

Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma

Who this might be right for
AdebrelimabHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00082082
What this trial is testing

A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
SciClone Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT04828486
What this trial is testing

Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage A Hepatocellular CarcinomaBCLC Stage B Hepatocellular Carcinoma+2 more
Mayo Clinic 14
Testing effectiveness (Phase 2)Study completedNCT01357486
What this trial is testing

Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCHILD B
University Hospital, Bordeaux 160
Next Page